Fig. 2 B

Ismail T et al. (2024)

Xla Wt +PFOS

NF35/36-37/38 (RNA-Seq)

Expression Phenotype

increased amount amy2a.L expression in the embryo
increased amount ass1.L expression in the embryo
increased amount cxcl8a.1.L expression in the embryo
increased amount olfm4.L expression in the embryo
increased amount uts2.L expression in the embryo
decreased amount c5ar1.L expression in embryo
decreased amount ddit4l.S expression in embryo
decreased amount fabp2.L expression in the embryo
decreased amount foxd3.L expression in the embryo
decreased amount rnf112.L expression in embryo
decreased amount slc14a2.L expression in embryo
increased amount arg1.L expression in embryo
increased amount otc.L expression in embryo
increased amount pla2g1b.L expression in embryo

Fig. 4. AB

Yang J et al. (2020)

Xla Wt + xbp1 MO

NF42 (immunohistochemistry)

Expression Phenotype
decreased amount amy2a.L expression in pancreas decreased amount amy2b.L expression in pancreas decreased amount gcg.L expression in pancreas increased amount ins.L expression in pancreas

Fig. 4 B, D

Yuan L et al. (2014)

Xla Wt + ern1 MO

NF 43

Anatomical Phenotype
abnormal foregut morphology abnormally coiled small intestine

Expression Phenotype
absent amy2a.L expression in pancreas absent ins.L expression in pancreas

Fig 7 B D

Yuan L et al. (2014)

Xla Wt + xbp1 MO

NF 43

Anatomical Phenotype
abnormal foregut morphology abnormally coiled small intestine

Expression Phenotype
absent amy2a.L expression in pancreas absent ins.L expression in pancreas

fig.5.a.2

Afelik S et al. (2006)

Xla Wt + ptf1a MO

NF43 (in situ hybridization)

Expression Phenotype
decreased amount amy2a.L expression in pancreas